The moderating role of allergy immunotherapy in asthma progression: Results of a population‐based cohort study

Schmitt, J et al. Allergy. 2019; 75: 596–602.

https://doi.org/10.1111/all.14020

The effect of allergy immunotherapy (AIT) on the development of asthma from mild to more severe was studied in this population‐based cohort study in Germany. Over 1.7 million asthmatics were included, 10% of whom received AIT. AIT was associated with a significant decrease in the probability of asthma severity worsening, particularly from GINA (global initiative for asthma) treatment step 1–3 (hazard ratio 0.87, 95% CI 0.8–0.95).

中文翻译：

---

最好的其他期刊

过敏免疫疗法在哮喘进展中的调节作用：一项基于人群的队列研究结果

Schmitt，J等。过敏。2019; 75：596-602。

https://doi.org/10.1111/all.14020

在德国的一项基于人群的队列研究中，研究了过敏免疫疗法（AIT）对哮喘从轻度到重度发展的影响。包括超过170万哮喘患者，其中10％接受了AIT。AIT与哮喘严重程度恶化的可能性显着降低有关，特别是在GINA（全球哮喘防治倡议）治疗步骤1-3中（危险比0.87，95％CI 0.8-0.95）。